Your browser doesn't support javascript.
loading
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.
Papp, K A; Reich, K; Paul, C; Blauvelt, A; Baran, W; Bolduc, C; Toth, D; Langley, R G; Cather, J; Gottlieb, A B; Thaçi, D; Krueger, J G; Russell, C B; Milmont, C E; Li, J; Klekotka, P A; Kricorian, G; Nirula, A.
Afiliação
  • Papp KA; Probity Medical Research and K Papp Clinical Research, Waterloo, ON, Canada.
  • Reich K; Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany.
  • Paul C; Paul Sabatier University, Toulouse, France.
  • Blauvelt A; Oregon Medical Research Center, Portland, OR, U.S.A.
  • Baran W; Wroclaw Medical University, Wroclaw, Poland.
  • Bolduc C; The University of Montreal and Innovaderm Research, Montreal, QC, Canada.
  • Toth D; XLR8 Medical Research and Probity Medical Research, Windsor, ON, Canada.
  • Langley RG; Dalhousie University, Halifax, NS, Canada.
  • Cather J; Modern Research Associates, Modern Dermatology, A Baylor Health Texas Affiliate, and Probity Medical Research, Dallas, TX, U.S.A.
  • Gottlieb AB; Tufts Medical Center, Boston, MA, U.S.A.
  • Thaçi D; University of Lübeck, Lübeck, Germany.
  • Krueger JG; The Rockefeller University, New York, NY, U.S.A.
  • Russell CB; Amgen Inc., Thousand Oaks, CA, U.S.A.
  • Milmont CE; Amgen Inc., Thousand Oaks, CA, U.S.A.
  • Li J; Amgen Inc., Thousand Oaks, CA, U.S.A.
  • Klekotka PA; Amgen Inc., Thousand Oaks, CA, U.S.A.
  • Kricorian G; Amgen Inc., Thousand Oaks, CA, U.S.A.
  • Nirula A; Amgen Inc., Thousand Oaks, CA, U.S.A.
Br J Dermatol ; 175(2): 273-86, 2016 Aug.
Article em En | MEDLINE | ID: mdl-26914406

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá